FGFR4 and chronic kidney disease: Taken together, these morphologic and metabolomic data suggest that expression of a constitutively active FGFR4 is sufficient to induce cardiac metabolic remodeling, which occurs prior to the onset of overt LVH and in a pattern that is similar to that observed in mice with CKD and wild-type FGFR4 expression.